FlowAid Medical wins CE Mark for sequential contraction compression device

Blood flow and circulatory enhancement focused device developer FlowAid Medical Technologies said yesterday it won CE Mark approval in the European Union for its FA100 SCCD sequential contraction compression device. The FA100 system uses electrically stimulated controlled contractions for sequential compression, eliminating the need for external compression and pressure to the leg, according to the New York-based company. The device operates using “specifically controlled wave of peristaltic contractions, distal to proximal, causing an increase in venous outflow from the limb” for treating chronic venous insufficiency, lymphedema and can help to prevent deep vein thrombosis, according to a press release. The company said the device’s ability to increase venous outflow can aid in treating peripheral artery disease and arterial insufficiency and that it can be used to treat microischemic neuropathy through hyperfusion. The post FlowAid Medical wins CE Mark for sequential contraction compression device appeared first on MassDevice.
Source: Mass Device - Category: Medical Equipment Authors: Tags: Regulatory/Compliance Vascular FlowAid Medical Technologies Source Type: news